Clinical Trial Update: Coenzyme Q10 for Neuroprotection in Paclitaxel-Induced Neuropathy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Coenzyme Q10 for neuroprotection against paclitaxel-induced neuropathy in breast cancer patients has completed. Sponsor is Damanhour Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Damanhour University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED